首页> 外文期刊>British Journal of Cancer >Inhibition by amiloride of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats
【24h】

Inhibition by amiloride of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats

机译:阿米洛利对N-甲基-N'-硝基-N-亚硝基胍诱导的Wistar大鼠胃癌发生的抑制作用

获取原文
获取外文期刊封面目录资料

摘要

The effects of amiloride on the incidence and histological types of gastric cancers in Wistar rats induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), and on the labelling index and proliferative fraction of gastric mucosa were investigated. After oral treatment with MNNG for 25 weeks, rats received s.c. injections of amiloride (0.25 mg kg-1 or 5.0 mg kg-1 body weight) in depot form every other day until the end of the experiment. Prolonged administration of 5.0 mg kg-1, but not 2.5 mg kg-1 of amiloride significantly decreased the incidence of gastric cancers in Week 52. However, it did not influence the histological features of the gastric cancers. It also significantly decreased the labelling index and proliferative fraction of the antral mucosa. These findings indicate that amiloride inhibits the development of gastric cancers, and that its effect may be related to its effect in decreasing cell proliferation of the antral mucosa.
机译:研究了阿米洛利对N-甲基-N'-硝基-N-亚硝基胍(MNNG)诱导的Wistar大鼠胃癌的发生和组织学类型的影响,以及对胃黏膜的标记指数和增殖分数的影响。用MNNG口服治疗25周后,大鼠接受皮下注射。每两天注射一次阿米洛利(0.25 mg kg-1或5.0 mg kg-1体重)的长效制剂,直至实验结束。在第52周,长期服用5.0 mg kg-1的阿米洛利,而不是2.5 mg kg-1的阿米洛利,显着降低了胃癌的发生率。但是,它并未影响胃癌的组织学特征。它还显着降低了胃窦黏膜的标记指数和增殖分数。这些发现表明,阿米洛利抑制胃癌的发展,并且其作用可能与减少胃窦粘膜细胞增殖的作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号